• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于非增强磁共振成像的放射组学模型用于鉴别胰腺腺鳞癌与胰腺导管腺癌

Non-enhanced magnetic resonance imaging-based radiomics model for the differentiation of pancreatic adenosquamous carcinoma from pancreatic ductal adenocarcinoma.

作者信息

Li Qi, Li Xuezhou, Liu Wenbin, Yu Jieyu, Chen Yukun, Zhu Mengmeng, Li Na, Liu Fang, Wang Tiegong, Fang Xu, Li Jing, Lu Jianping, Shao Chengwei, Bian Yun

机构信息

Department of Radiology, Changhai Hospital, Navy Medical University, Shanghai, China.

Department of Radiology, 96601 Military Hospital of PLA, Huangshan, Anhui, China.

出版信息

Front Oncol. 2023 Jan 23;13:1108545. doi: 10.3389/fonc.2023.1108545. eCollection 2023.

DOI:10.3389/fonc.2023.1108545
PMID:36756153
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9900003/
Abstract

PURPOSE

To evaluate the diagnostic performance of radiomics model based on fully automatic segmentation of pancreatic tumors from non-enhanced magnetic resonance imaging (MRI) for differentiating pancreatic adenosquamous carcinoma (PASC) from pancreatic ductal adenocarcinoma (PDAC).

MATERIALS AND METHODS

In this retrospective study, patients with surgically resected histopathologically confirmed PASC and PDAC who underwent MRI scans between January 2011 and December 2020 were included in the study. Multivariable logistic regression analysis was conducted to develop a clinical and radiomics model based on non-enhanced T1-weighted and T2-weighted images. The model performances were determined based on their discrimination and clinical utility. Kaplan-Meier and log-rank tests were used for survival analysis.

RESULTS

A total of 510 consecutive patients including 387 patients (age: 61 ± 9 years; range: 28-86 years; 250 males) with PDAC and 123 patients (age: 62 ± 10 years; range: 36-84 years; 78 males) with PASC were included in the study. All patients were split into training (n=382) and validation (n=128) sets according to time. The radiomics model showed good discrimination in the validation (AUC, 0.87) set and outperformed the MRI model (validation set AUC, 0.80) and the ring-enhancement (validation set AUC, 0.74).

CONCLUSIONS

The radiomics model based on non-enhanced MRI outperformed the MRI model and ring-enhancement to differentiate PASC from PDAC; it can, thus, provide important information for decision-making towards precise management and treatment of PASC.

摘要

目的

评估基于非增强磁共振成像(MRI)对胰腺肿瘤进行全自动分割的放射组学模型在鉴别胰腺腺鳞癌(PASC)与胰腺导管腺癌(PDAC)方面的诊断性能。

材料与方法

在这项回顾性研究中,纳入了2011年1月至2020年12月期间接受MRI扫描且经手术切除并经组织病理学证实为PASC和PDAC的患者。基于非增强T1加权和T2加权图像进行多变量逻辑回归分析,以建立临床和放射组学模型。根据模型的辨别力和临床实用性来确定其性能。采用Kaplan-Meier法和对数秩检验进行生存分析。

结果

本研究共纳入510例连续患者,其中387例(年龄:61±9岁;范围:28 - 86岁;男性250例)为PDAC患者,123例(年龄:62±10岁;范围:36 - 84岁;男性78例)为PASC患者。所有患者按时间分为训练集(n = 382)和验证集(n = 128)。放射组学模型在验证集(AUC,0.87)中显示出良好的辨别力,优于MRI模型(验证集AUC,0.80)和环形强化(验证集AUC,0.74)。

结论

基于非增强MRI的放射组学模型在鉴别PASC与PDAC方面优于MRI模型和环形强化;因此,它可为PASC的精确管理和治疗决策提供重要信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83c5/9900003/dfdc0c80f926/fonc-13-1108545-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83c5/9900003/147bfa54aa63/fonc-13-1108545-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83c5/9900003/901844656dc7/fonc-13-1108545-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83c5/9900003/f020a06a4222/fonc-13-1108545-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83c5/9900003/2eb23487911d/fonc-13-1108545-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83c5/9900003/314386a5b063/fonc-13-1108545-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83c5/9900003/dfdc0c80f926/fonc-13-1108545-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83c5/9900003/147bfa54aa63/fonc-13-1108545-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83c5/9900003/901844656dc7/fonc-13-1108545-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83c5/9900003/f020a06a4222/fonc-13-1108545-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83c5/9900003/2eb23487911d/fonc-13-1108545-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83c5/9900003/314386a5b063/fonc-13-1108545-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83c5/9900003/dfdc0c80f926/fonc-13-1108545-g006.jpg

相似文献

1
Non-enhanced magnetic resonance imaging-based radiomics model for the differentiation of pancreatic adenosquamous carcinoma from pancreatic ductal adenocarcinoma.基于非增强磁共振成像的放射组学模型用于鉴别胰腺腺鳞癌与胰腺导管腺癌
Front Oncol. 2023 Jan 23;13:1108545. doi: 10.3389/fonc.2023.1108545. eCollection 2023.
2
Fully automated magnetic resonance imaging-based radiomics analysis for differentiating pancreatic adenosquamous carcinoma from pancreatic ductal adenocarcinoma.基于全自动磁共振成像的放射组学分析用于鉴别胰腺腺鳞癌与胰腺导管腺癌
Abdom Radiol (NY). 2023 Jun;48(6):2074-2084. doi: 10.1007/s00261-023-03801-8. Epub 2023 Mar 25.
3
Preoperative Radiomics Approach to Evaluating Tumor-Infiltrating CD8 T Cells in Patients With Pancreatic Ductal Adenocarcinoma Using Noncontrast Magnetic Resonance Imaging.术前放射组学方法:利用非增强磁共振成像评估胰腺导管腺癌患者肿瘤浸润性CD8 T细胞
J Magn Reson Imaging. 2022 Mar;55(3):803-814. doi: 10.1002/jmri.27871. Epub 2021 Aug 6.
4
Computed Tomography-Based Radiomics Signature for the Preoperative Differentiation of Pancreatic Adenosquamous Carcinoma From Pancreatic Ductal Adenocarcinoma.基于计算机断层扫描的放射组学特征用于术前鉴别胰腺腺鳞癌与胰腺导管腺癌
Front Oncol. 2020 Aug 25;10:1618. doi: 10.3389/fonc.2020.01618. eCollection 2020.
5
Noncontrast Magnetic Resonance Radiomics and Multilayer Perceptron Network Classifier: An approach for Predicting Fibroblast Activation Protein Expression in Patients With Pancreatic Ductal Adenocarcinoma.非对比磁共振影像组学和多层感知机网络分类器:预测胰腺导管腺癌患者成纤维细胞激活蛋白表达的一种方法。
J Magn Reson Imaging. 2021 Nov;54(5):1432-1443. doi: 10.1002/jmri.27648. Epub 2021 Apr 22.
6
Artificial Intelligence to Predict Lymph Node Metastasis at CT in Pancreatic Ductal Adenocarcinoma.人工智能预测胰腺导管腺癌 CT 下淋巴结转移。
Radiology. 2023 Jan;306(1):160-169. doi: 10.1148/radiol.220329. Epub 2022 Sep 6.
7
Application of Unenhanced Computed Tomography Texture Analysis to Differentiate Pancreatic Adenosquamous Carcinoma from Pancreatic Ductal Adenocarcinoma.非增强计算机断层扫描纹理分析在鉴别胰腺腺鳞癌与胰腺导管腺癌中的应用
Curr Med Sci. 2022 Feb;42(1):217-225. doi: 10.1007/s11596-022-2535-2. Epub 2022 Jan 28.
8
Preoperative Prediction of Lymph Node Metastasis of Pancreatic Ductal Adenocarcinoma Based on a Radiomics Nomogram of Dual-Parametric MRI Imaging.基于双参数MRI成像的影像组学列线图对胰腺导管腺癌淋巴结转移的术前预测
Front Oncol. 2022 Jul 6;12:927077. doi: 10.3389/fonc.2022.927077. eCollection 2022.
9
Two nomograms for differentiating mass-forming chronic pancreatitis from pancreatic ductal adenocarcinoma in patients with chronic pancreatitis.两种列线图用于区分慢性胰腺炎患者的肿块型慢性胰腺炎和胰腺导管腺癌。
Eur Radiol. 2022 Sep;32(9):6336-6347. doi: 10.1007/s00330-022-08698-3. Epub 2022 Apr 8.
10
Magnetic Resonance Radiomics and Machine-learning Models: An Approach for Evaluating Tumor-stroma Ratio in Patients with Pancreatic Ductal Adenocarcinoma.磁共振影像组学和机器学习模型:一种评估胰腺导管腺癌患者肿瘤间质比的方法。
Acad Radiol. 2022 Apr;29(4):523-535. doi: 10.1016/j.acra.2021.08.013. Epub 2021 Sep 22.

本文引用的文献

1
Research advances and treatment perspectives of pancreatic adenosquamous carcinoma.胰腺腺鳞癌的研究进展与治疗前景
Cell Oncol (Dordr). 2023 Feb;46(1):1-15. doi: 10.1007/s13402-022-00732-2. Epub 2022 Nov 1.
2
Artificial Intelligence to Predict Lymph Node Metastasis at CT in Pancreatic Ductal Adenocarcinoma.人工智能预测胰腺导管腺癌 CT 下淋巴结转移。
Radiology. 2023 Jan;306(1):160-169. doi: 10.1148/radiol.220329. Epub 2022 Sep 6.
3
AI-Driven Image Analysis in Central Nervous System Tumors-Traditional Machine Learning, Deep Learning and Hybrid Models.
中枢神经系统肿瘤中的人工智能驱动图像分析——传统机器学习、深度学习及混合模型
J Biotechnol Biomed. 2022;5(1):1-19. doi: 10.26502/jbb.2642-91280046. Epub 2022 Jan 10.
4
Application of Unenhanced Computed Tomography Texture Analysis to Differentiate Pancreatic Adenosquamous Carcinoma from Pancreatic Ductal Adenocarcinoma.非增强计算机断层扫描纹理分析在鉴别胰腺腺鳞癌与胰腺导管腺癌中的应用
Curr Med Sci. 2022 Feb;42(1):217-225. doi: 10.1007/s11596-022-2535-2. Epub 2022 Jan 28.
5
Application of artificial intelligence for diagnosis of pancreatic ductal adenocarcinoma by EUS: A systematic review and meta-analysis.人工智能在超声内镜诊断胰腺导管腺癌中的应用:一项系统评价和荟萃分析。
Endosc Ultrasound. 2022 Jan-Feb;11(1):17-26. doi: 10.4103/EUS-D-20-00219.
6
Early Prediction of Acute Biliary Pancreatitis Using Clinical and Abdominal CT Features.基于临床和腹部 CT 特征的急性胆源性胰腺炎早期预测。
Radiology. 2022 Jan;302(1):118-126. doi: 10.1148/radiol.2021210607. Epub 2021 Oct 12.
7
XGBoost Classifier Based on Computed Tomography Radiomics for Prediction of Tumor-Infiltrating CD8 T-Cells in Patients With Pancreatic Ductal Adenocarcinoma.基于计算机断层扫描影像组学的XGBoost分类器预测胰腺导管腺癌患者肿瘤浸润性CD8 T细胞
Front Oncol. 2021 May 19;11:671333. doi: 10.3389/fonc.2021.671333. eCollection 2021.
8
Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.胰腺导管腺癌临床实践指南(第 2.2021 版),NCCN 肿瘤学临床实践指南。
J Natl Compr Canc Netw. 2021 Apr 1;19(4):439-457. doi: 10.6004/jnccn.2021.0017.
9
PD-L1 expression and surgical outcomes of adenosquamous carcinoma of the pancreas in a single-centre study of 56 lesions.一项针对56个病灶的单中心研究:胰腺腺鳞癌的程序性死亡受体配体1(PD-L1)表达与手术结果
Pancreatology. 2021 Aug;21(5):920-927. doi: 10.1016/j.pan.2021.03.004. Epub 2021 Mar 17.
10
Use of ring-enhancement and focal necrosis to differentiate pancreatic adenosquamous carcinoma from pancreatic ductal adenocarcinoma on CT and MRI.利用环形增强和局灶性坏死在 CT 和 MRI 上鉴别胰腺腺鳞癌和胰腺导管腺癌。
Clin Imaging. 2021 May;73:134-138. doi: 10.1016/j.clinimag.2020.11.041. Epub 2020 Dec 3.